Cargando…
Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
SIMPLE SUMMARY: Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent extraintestinal manifestation in patients with Inflammatory Bowel Disease (IBD). Liver fibrosis is the determinant long-term prognostic marker in patients with NAFLD because it is associated with progression to liver cirrhosis...
Autores principales: | Martínez-Domínguez, Samuel J., García-Mateo, Sandra, Laredo, Viviana, Gargallo-Puyuelo, Carla J., Gallego Llera, Beatriz, López de la Cruz, Julia, Gomollón, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340150/ https://www.ncbi.nlm.nih.gov/pubmed/37444477 http://dx.doi.org/10.3390/cancers15133367 |
Ejemplares similares
-
Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021) -
How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
por: Laredo, Viviana, et al.
Publicado: (2022) -
Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management
por: Laredo, Viviana, et al.
Publicado: (2023) -
Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease
por: García-Mateo, Sandra, et al.
Publicado: (2023) -
Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract
por: Ber, Yolanda, et al.
Publicado: (2021)